A silk fibroin based hepatocarcinoma model and the assessment of the drug response in hyaluronan-binding protein 1 overexpressed HepG2 cells

Biomaterials

Volumn 34, Issue 37, 2013, Pages 9462-9474

  Kundu, Banani ^a   Saha, Paramita ^b   Datta, Kasturi ^b   Kundu, Subhas C ^a  

^a INDIAN INSTITUTE OF TECHNOLOGY   (India)

^b JAWAHARLAL NEHRU UNIVERSITY   (India)

Author keywords

4 Methylumbelliferone; Drug screening; Hyaluronan binding protein 1; Scaffold; Silk fibroin

Indexed keywords

4-METHYLUMBELLIFERONE; CELLULAR MORPHOLOGY; DRUG SCREENING; EXTRACELLULAR MATRICES; HYALURONAN-BINDING PROTEINS; MULTICELLULAR AGGREGATES; SILK FIBROIN; THERAPEUTIC INTERVENTION;

CABLES; CELL CULTURE; CELL PROLIFERATION; CELLS; DRUG THERAPY; ENZYME INHIBITION; HYALURONIC ACID; LAKES; MOLECULAR BIOLOGY; PROTEINS; SCAFFOLDS; THREE DIMENSIONAL; TUMORS;

SCAFFOLDS (BIOLOGY);

ANTINEOPLASTIC AGENT; GROWTH PROMOTOR; HYALURONAN BINDING PROTEIN 1; HYALURONIC ACID BINDING PROTEIN; HYMECROMONE; PROTEIN KINASE B; PROTEIN KINASE C; PROTEIN P53; SILK FIBROIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTHERAEA MYLITTA; ARTICLE; BOMBYX MORI; CANCER GROWTH; CELL ADHESION; CELL PROLIFERATION; CELL STRAIN HEPG2; CELL STRAIN HEPR21; CELL STRUCTURE; CELL TRANSFORMATION; CELL VIABILITY; CONTROLLED STUDY; DOWN REGULATION; DRUG RESPONSE; GENE OVEREXPRESSION; IN VITRO STUDY; LIVER CELL CARCINOMA; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; SUPPRESSOR CELL; UPREGULATION;

ANTHERAEA MYLITTA; MORUS (ANGIOSPERM);

4-METHYLUMBELLIFERONE; DRUG SCREENING; HYALURONAN-BINDING PROTEIN 1; SCAFFOLD; SILK FIBROIN;

ANIMALS; ANTINEOPLASTIC AGENTS; CARCINOMA, HEPATOCELLULAR; CARRIER PROTEINS; DRUG SCREENING ASSAYS, ANTITUMOR; FIBROINS; HEP G2 CELLS; HUMANS; HYMECROMONE; LIVER NEOPLASMS; MITOCHONDRIAL PROTEINS; TISSUE SCAFFOLDS; UP-REGULATION;

EID: 84884813681     PISSN: 01429612     EISSN: 18785905     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2013.08.047     Document Type: Article

References (50)

1. Nyga A., Cheema U., Loizidou M. 3D tumour models: novel invitro approaches to cancer studies. JCell Commun Signal 2011, 5:239-248.
2. Koyama H., Hibi T., Isogai Z., Yoneda M., Fujimori M., Amano J., et al. Hyperproduction of hyaluronan in neu-induced mammary tumor accelerates angiogenesis through stromal cell recruitment. Possible involvement of versican/PG-M. Am J Pathol 2007, 170:1086-1099.
3. Toole B.P., Wight T.N., Tammi M. Hyaluronan-cell interactions in cancer and vascular disease. JBiol Chem 2002, 277:4593-4596.
4. Toole B.P., Hascall V.C. Hyaluronan and tumor growth. Am J Pathol 2002, 161:745-747.
5. Stern R. Hyaluronan metabolism: a major paradox in cancer biology. Pathol Biol 2005, 53:372-382.
6. Ghosh I., Chowdhury A.R., Rajeswari M.R., Datta K. Differential expression of hyaluronic acid binding protein 1 (HABP1)/P32/C1QBP during progression of epidermal carcinoma. Mol Cell Biochem 2004, 267:133-139.
7. Rubinstein D.B., Stortchevoi A., Boosalis M., Ashfaq R., Ghebrehiwet B., Peerschke E.I., et al. Receptor for the globular heads of C1q (gC1q-R, p33, hyaluronan-binding protein) is preferentially expressed by adenocarcinoma cells. Int J Cancer 2004, 110:741-750.
8. Prakash M., Kale S., Ghosh I., Kundu G.C., Datta K. Hyaluronan-binding protein (HABP1/p32/gC1qR) induces melanoma cell migration and tumor growth by NF-kappa B dependent MMP-2 activation through integrin α(v)β(3) interaction. Cell Signal 2011, 23:1563-1577.
9. Fogal V., Zhang L., Krajewski S., Rouslahti E. Mitochondrial/cell-surface protein p32/gC1qR as a molecular target in tumor cells and tumor stroma. Cancer Res 2008, 68:7210-7218.
10. Fogal V., Richardson A.D., Karmali P.P., Scheffler I.E., Smith J.W., Ruoslahti E. Mitochondrial p32 protein is a critical regulator of tumor metabolism via maintenance of oxidative phosphorylation. Mol Cell Biol 2010, 30:1303-1318.
11. Chen Y.B., Jiang C.T., Zhang G.Q., Wang J.S., Pang D.A. Increased expression of hyaluronic acid binding protein 1 is correlated with poor prognosis in patients with breast cancer. JSurg Oncol 2009, 100:382-386.
12. Chowdhury A.R., Ghosh I., Datta K. Excessive reactive oxygen species induces apoptosis in fibroblasts: role of mitochondrially accumulated hyaluronic acid binding protein 1 (HABP1/p32/gC1qR). Exp Cell Res 2008, 314:651-667.
13. Huang Z.Z., Chen C., Zeng Z., Yang H., Oh J., Chen L., et al. Mechanism and significance of increased glutathione level in human hepatocellular carcinoma and liver regeneration. FASEB 2001, 15:19-21.
14. Murakami C., Hirakawa Y., Inui H., Nakano Y., Yoshida H. Effects of epigallocatechin 3-O-gallate on cellular antioxidative system in HepG2 cells. JNutr Sci Vitaminol 2002, 48:89-94.
15. Kaul R., Saha P., Saradhi M., Prasad R.L., Chatterjee S., Ghosh I., et al. Overexpression of hyaluronan-binding protein 1 (HABP1/p32/gC1qR) in HepG2 cells leads to increased hyaluronan synthesis and cell proliferation by up-regulation of cyclin D1 in AKT-dependent pathway. JBiol Chem 2012, 287:19750-19764.
16. Cukierman E., Pankov R., Stevens D.R., Yamada K.M. Taking cell-matrix adhesions to the third dimension. Science 2001, 294:1708-1712.
17. Hemler M.E., Mannion B.A., Berditchevski F. Review association of TM4SF proteins with integrins: relevance to cancer. Biochim Biophys Acta 1996, 1287:67-71.
18. Dedhar S., Hannigan G.E. Integrin cytoplasmic interactions and bidirectional transmembrane signalling. Curr Opin Cell Biol 1996, 8:657-669.
19. Feder-Mengus C., Ghosh S., Reschner A., Martin I., Spagnoli G.C. New dimensions in tumor immunology: what does 3D culture reveal?. Trends Mol Med 2008, 14:333-340.
20. Erler J.T., Linding R. Network-based drugs and biomarkers. JPathol 2010, 220:290-296.
21. Chen P.C., Huang Y.Y., Juang J.L. MEMS micro well and micro column arrays: novel methods for high-throughput cell-based assays. Lab Chip 2011, 11:3619-3625.
22. Verbridge S.S., Choi N.W., Zheng Y., Brooks D.J., Stroock A.D., Fischbach C. Oxygen-controlled three-dimensional cultures to analyze tumor angiogenesis. Tissue Eng Part A 2010, 16:2133-2141.
23. Datta A., Ghosh A.K., Kundu S.C. Differential expression of the fibroin gene in developmental stages of silkworm, Antheraea mylitta (Saturniidae). Comp Biochem Physiol B 2001, 129:197-204.
24. Talukdar S., Mandal M., Hutmacher D.W., Russell P.J., Soekmadji C., Kundu S.C. Engineered silk fibroin protein 3D matrices for invitro tumor model. Biomaterials 2011, 32:2149-2159.
25. Kundu B., Rajkhowa R., Kundu S.C., Wang X. Silk fibroin biomaterials for tissue regenerations. Adv Drug Deliv Rev 2013, 65:457-470.
26. Patra C., Talukdar S., Novoyatleva T., Velagala S.R., Mühlfeld C., Kundu B., et al. Silk protein fibroin from Antheraea mylitta for cardiac tissue engineering. Biomaterials 2012, 33:2673-2680.
27. Kundu B., Kundu S.C. Silk sericin/polyacrylamide in situ forming hydrogels for dermal reconstruction. Biomaterials 2012, 33:7456-7467.
28. Hwang N.S., Varghese S., Elisseeff J.H. Cartilage tissue engineering: directed differentiation of embryonic stem cells in three-dimensional hydrogel culture. Methods Mol Biol 2007, 407:351-373.
29. Whang K., Healy K.E., Elenz D.R., Nam E.K., Tsai D.C., Thomas C.H., et al. Engineering bone regeneration with bio-absorbable scaffolds with novel microarchitecture. Tissue Eng 1999, 5:35-51.
30. Jacks T., Weinberg R.A. Taking the study of cancer cell survival to a new dimension. Cell 2002, 111:923-925.
31. Bortner C.D., Cidlowski J.A. Apoptotic volume decrease and the incredible shrinking cell. Cell Death Differ 2002, 9:1307-1310.
32. Itano N., Zhuo L., Kimata K. Impact of the hyaluronan-rich tumor microenvironment on cancer initiation and progression. Cancer Sci 2008, 99:1720-1725.
33. Nakamura T., Takagaki K., Shibata S., Tanaka K., Higuchi T., Endo M. Hyaluronic-acid-deficient extracellular matrix induced by addition of 4- methylumbelliferone to the medium of cultured human skin fibroblasts. Biochem Biophys Res Commun 1995, 208:470-475.
34. Morohashi H., Kon A., Nakai M., Yamaguchi M., Kakizaki I., Yoshihara S., et al. Study of hyaluronan synthase inhibitor, 4- methylumbelliferone derivatives on human pancreatic cancer cell (KP1-NL). Biochem Biophys Res Commun 2006, 345:1454-1459.
35. Wu T.T., Hsieh Y.H., Hsieh Y.S., Liu J.Y. Reduction of PKC alpha decreases cell proliferation, migration, and invasion of human malignant hepatocellular carcinoma. Cell Biochem 2008, 103:9-20.
36. Toole B.P. Hyaluronan and its binding proteins, the hyaladherins. Curr Opin Cell Biol 1990, 2:839-844.
37. Stern R. Association between cancer and "acid mucopolysaccharides": an old concept comes of age finally. Semin Cancer Biol 2008, 18:238-243.
38. Glicklis R., Shapiro L., Agbaria R., Merchuk J.C., Cohen S. Hepatocyte behavior within three-dimensional porous alginate scaffolds. Biotechnol Bioeng 2000, 67:344-353.
39. Allen J.W., Bhatia S.N. Improving the next generation of bioartificial liver devices. Semin Cell Dev Biol 2002, 13:447-454.
40. Parsons-Wingerter P.A., Saltzman W.M. Growth versus function in the three-dimensional culture of single and aggregated hepatocytes within collagen gels. Biotechnol Prog 1993, 9:600-607.
41. Kosaki R., Watanabe K., Yamaguchi Y. Overproduction of hyaluronan by expression of the hyaluronan synthase Has2 enhances anchorage-independent growth and tumorigenicity. Cancer Res 1999, 59:1141-1145.
42. Turley E.A., Noble P.W., Bourguignon L.Y. Signaling properties of hyaluronan receptors. JBiol Chem 2002, 277:4589-4592.
43. Kultti A., Pasonen-Seppänen S., Jauhiainen M., Rilla K.J., Kärnä R., Pyöriä E., et al. 4-Methylumbelliferone inhibits hyaluronan synthesis by depletion of cellular UDP-glucuronic acid and downregulation of hyaluronan synthase 2 and 3. Exp Cell Res 2009, 315:1914-1923.
44. Nakazawa H., Yoshihara S., Kudo D., Morohashi H., Kakizaki I., Kon A., et al. 4-methylumbelliferone, a hyaluronan synthase suppressor, enhances the anticancer activity of gemcitabine in human pancreatic cancer cells. Cancer Chemother Pharmacol 2006, 57:165-170.
45. Kultti A., Rilla K., Tiihonen R., Spicer A.P., Tammi R.H., Tammi M.I. Hyaluronan synthesis induces microvillus-like cell surface protrusions. JBiol Chem 2006, 281:15821-15828.
46. Yamaguchi H., Condeelis J. Regulation of the actin cytoskeleton in cancer cell migration and invasion. Biochim Biophys Acta 2007, 1773:642-652.
47. Gourlay C.W., Carpp L.N., Timpson P., Winder S.J., Ayscough K.R. Arole for the actin cytoskeleton in cell death and aging in yeast. JCell Biol 2004, 164:803-809.
48. Jain R.K., Stylianopoulos T. Delivering nanomedicine to solid tumors. Nat Rev Clin Oncol 2010, 7:653-664.
49. Itano N., Kimata K. Altered hyaluronan biosynthesis in cancer progression. Semin Cancer Biol 2008, 18:268-274.
50. Blobe G.C., Obeid L.M., Hannun Y.A. Regulation of protein kinase C and role in cancer biology. Cancer Metastasis Rev 1994, 13:411-431.